Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
1.460
-0.260 (-15.12%)
At close: May 12, 2025, 4:00 PM
1.460
0.00 (0.00%)
After-hours: May 12, 2025, 8:00 PM EDT

Protalix BioTherapeutics Statistics

Total Valuation

PLX has a market cap or net worth of $113.93 million. The enterprise value is $84.42 million.

Market Cap 113.93M
Enterprise Value 84.42M

Important Dates

The last earnings date was Friday, May 9, 2025, before market open.

Earnings Date May 9, 2025
Ex-Dividend Date n/a

Share Statistics

PLX has 78.03 million shares outstanding. The number of shares has decreased by -5.05% in one year.

Current Share Class 78.03M
Shares Outstanding 78.03M
Shares Change (YoY) -5.05%
Shares Change (QoQ) -26.56%
Owned by Insiders (%) 10.71%
Owned by Institutions (%) 7.02%
Float 59.15M

Valuation Ratios

The trailing PE ratio is 33.97 and the forward PE ratio is 2.70.

PE Ratio 33.97
Forward PE 2.70
PS Ratio 1.79
Forward PS 1.64
PB Ratio 2.57
P/TBV Ratio 2.52
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 21.60
EV / Sales 1.41
EV / EBITDA 14.17
EV / EBIT 18.24
EV / FCF n/a

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.12.

Current Ratio 2.49
Quick Ratio 1.62
Debt / Equity 0.12
Debt / EBITDA 0.69
Debt / FCF n/a
Interest Coverage 6.83

Financial Efficiency

Return on equity (ROE) is 10.42% and return on invested capital (ROIC) is 5.43%.

Return on Equity (ROE) 10.42%
Return on Assets (ROA) 3.53%
Return on Invested Capital (ROIC) 5.43%
Return on Capital Employed (ROCE) 9.34%
Revenue Per Employee $280,582
Profits Per Employee $18,347
Employee Count 213
Asset Turnover 0.73
Inventory Turnover 1.43

Taxes

In the past 12 months, PLX has paid $1.25 million in taxes.

Income Tax 1.25M
Effective Tax Rate 24.19%

Stock Price Statistics

The stock price has increased by +32.73% in the last 52 weeks. The beta is -0.05, so PLX's price volatility has been lower than the market average.

Beta (5Y) -0.05
52-Week Price Change +32.73%
50-Day Moving Average 2.51
200-Day Moving Average 1.79
Relative Strength Index (RSI) 24.19
Average Volume (20 Days) 1,302,819

Short Selling Information

The latest short interest is 740,272, so 0.95% of the outstanding shares have been sold short.

Short Interest 740,272
Short Previous Month 650,638
Short % of Shares Out 0.95%
Short % of Float 1.25%
Short Ratio (days to cover) 1.02

Income Statement

In the last 12 months, PLX had revenue of $59.76 million and earned $3.91 million in profits. Earnings per share was $0.04.

Revenue 59.76M
Gross Profit 29.87M
Operating Income 4.63M
Pretax Income 6.77M
Net Income 3.91M
EBITDA 5.96M
EBIT 4.63M
Earnings Per Share (EPS) $0.04
Full Income Statement

Balance Sheet

The company has $34.74 million in cash and $5.24 million in debt, giving a net cash position of $29.51 million or $0.38 per share.

Cash & Cash Equivalents 34.74M
Total Debt 5.24M
Net Cash 29.51M
Net Cash Per Share $0.38
Equity (Book Value) 45.21M
Book Value Per Share 0.57
Working Capital 36.19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$572,000 and capital expenditures -$990,000, giving a free cash flow of -$1.56 million.

Operating Cash Flow -572,000
Capital Expenditures -990,000
Free Cash Flow -1.56M
FCF Per Share -$0.02
Full Cash Flow Statement

Margins

Gross margin is 49.97%, with operating and profit margins of 7.74% and 6.54%.

Gross Margin 49.97%
Operating Margin 7.74%
Pretax Margin 8.63%
Profit Margin 6.54%
EBITDA Margin 9.97%
EBIT Margin 7.74%
FCF Margin n/a

Dividends & Yields

PLX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield 5.05%
Shareholder Yield 5.05%
Earnings Yield 3.43%
FCF Yield -1.37%

Analyst Forecast

The average price target for PLX is $15.00, which is 927.40% higher than the current price. The consensus rating is "Strong Buy".

Price Target $15.00
Price Target Difference 927.40%
Analyst Consensus Strong Buy
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on December 20, 2019. It was a reverse split with a ratio of 0.1:1.

Last Split Date Dec 20, 2019
Split Type Reverse
Split Ratio 0.1:1

Scores

Altman Z-Score n/a
Piotroski F-Score 3